Opendata, web and dolomites

3L-HeCoMe

Advanced manufacturing process to obtain a partially Bio-Resorbable Adhesive/Non-Adhesive Triple Layer Mesh for intra-peritoneal Hernia Containment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 3L-HeCoMe project word cloud

Explore the words cloud of the 3L-HeCoMe project. It provides you a very rough idea of what is the project "3L-HeCoMe" about.

final    intraperitoneal    viscera    surgery    adhesions    732    oriented    displacement    452    output    substitute    faster    containment    procedure    anti    industrial    iptawh    considering    tissues    adhesive    life    repairs    post       700    device    36    avoiding    sales    surfaces    259    applicability    reducing    3l    hernia    penetration    healthcare    ing    giving    materials    md    routes    operation    fs    adhesion    parietal    societal    operative    cagr    hecome    reduce    mechanical    technologies    bioresorption    sme    amount    qualify    medical    position    treatment    innovate    markets    2019    complications    surgical    preventing    500    fixation    usd    hernias    mininvasive    innovative    abdominal    decreasing    actual    recurrence    surgeons    hospitalization    million    wall    prosthetic    market    quality    patients    solid    efficient    year    amounts    feasibility    income    repair    simplified    global    ventral    solutions    mesh    chemical    partial    customization    400    constituting    instruments    thanks   

Project "3L-HeCoMe" data sheet

The following table provides information about the project.

Coordinator
HERNIAMESH SRL 

Organization address
address: Via Fratelli Meliga 1/C
city: Chivasso
postcode: 10034
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.herniamesh.it
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HERNIAMESH SRL IT (Chivasso) coordinator 50˙000.00
2    TISSUEMED LIMITED UK (LEEDS) participant 0.00

Map

 Project objective

3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications still occur, namely recurrence due to prosthetic displacement and adhesions between viscera and prosthetic surfaces. Considering estimated costs for each ventral hernia repair in Europe, costs due only to recurrence amount to 36.732.000 €/year. The main aim of 3L-HeCoMe Feasibility Study(FS) is the development of an innovative process supported by enabling technologies derived from other applications and by the use of advanced materials to produce a unique medical device for the Intraperitoneal Treatment of Abdominal Wall Hernias (IPTAWH). The produced IPTAWH medical device (IPTAWH-MD) aims at preventing post-surgery problems and avoiding, or decreasing, use of mechanical surgery instruments for the mesh fixation. The IPTAWH-MD will reduce the surgical duration and costs, thanks to the following characteristics: ‐ chemical adhesive properties to parietal tissues ‐ anti-adhesion properties to viscera ‐ adequate mechanical properties, ‐ partial bioresorption. FS objectives: ‐ investigate technical development, process customization and applicability ‐ qualify 3L-HeCoMe process production output and constituting materials ‐ assess market potential and penetration routes Final users are surgeons oriented towards simplified, faster and mininvasive procedure, in the global market, which amounts to about USD 500 million and has an estimated CAGR of 7.5%, bringing to 700 million in 2019. The resulting MD will substitute actual products, giving a solid position to the SME in global markets and increasing the income, with potential sales of 259.000 – 452.000 €/year from year 1 to 5. 3L-HeCoMe addresses societal issues avoiding hernia operation recurrence, improving quality of life of patients by reducing hospitalization and reducing healthcare

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "3L-HECOME" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "3L-HECOME" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

NANOHIGH (2015)

High volume production facility for high accuracy nanocapsules

Read More  

MySpark (2016)

The Complete Solution for Fast and Cost-efficient Yeast Separation Process in Production of High Quality Sparkling Wine

Read More